| |
Controls (n = 20)
|
Patients (n = 22)
|
p
|
|---|
|
LV-EF (%)
|
65 ± 4
|
62 ± 12
|
0.58
|
|
LV-EDV (ml)
|
109 ± 27
|
124 ± 48
|
0.38
|
|
LV-ESV (ml)
|
38 ± 13
|
51 ± 37
|
0.35
|
|
LV-SV
|
71 ± 15
|
74 ± 17
|
0.76
|
|
LV-EDD
|
45 ± 5
|
48 ± 6
|
0.06
|
|
LA (cm2)
|
20 ± 3
|
21 ± 6
|
0.97
|
|
IVS (mm)
|
10 ± 2
|
10 ± 2
|
0.23
|
|
PA (mm)
|
24 ± 4
|
25 ± 3
|
0.27
|
|
LV mass (g)
|
85 ± 20
|
89 ± 25
|
0.83
|
|
LGE per patient
|
-
|
9 (41%)
| |
|
epicardial
|
-
|
3 (14%)
| |
|
intramural
|
-
|
2 (9%)
| |
|
transmural
|
-
|
-
| |
|
subendocardial
|
-
|
4 (18%)
| |
|
% LV mass
|
-
|
7.1 ± 6
| |
|
Native T1 (ms)
|
952 (923–960)
|
982 (958–1007)
|
0.003
|
|
Post-contrast T1 (ms)
|
524 (500–529)
|
481 (462–527)
|
0.02
|
|
ECV (%)
|
24.5 (23–25)
|
28 (25–31)
|
<0.001
|
|
T2 (ms)
|
49 (48–51)
|
53 (50–55)
|
<0.001
|
- All values are n or mean ± SD or interquartile ranges. CMR cardiac magnetic resonance, LV left-ventricular, EF ejection fraction, EDV end-diastolic volume, ESV end-systolic volume, SV stroke volume, EDD end-diastolic diameter, LA left atrium, IVS interventricular septum, PA pulmonary artery, LGE late gadolinium enhancement, ECV extracellular volume
